ERCCP　北海道大学　臨床薬学教育研究センター

原著論文

Mori A, Kato I, Narumi K, Takekuma Y, Kashiwagi H, Sato Y, Sugawara M, Kobayashi M. Quantitative analysis of communication changes in online medication counseling ―Using the Roter Interaction Analysis System. Res Social Adm Pharm. 20(1):36-42(2024). doi: 10.1016/j.sapharm.2023.10.001.（査読有）

Kato I, Ogawa Y, Yakushiji F, Ogura J, Kobayashi M, Shindo N, Ichikawa S, Maenaka K, Sakaitani M. Beneficial effects of a new neuroprotective compound in neuronal cells and MPTP-administered mouse model of Parkinson’s disease. Chem. Commun. in printing(2023). doi: 10.1039/D3CC03069E.（査読有）

Yamaguchi A, Saito Y, Narumi K, Furugen A, Takekuma Y, Shinagawa N, Shimizu Y, Dosaka-Akita H, Sugawara M, Kobayashi M. Association between skin immune-related adverse events (irAEs) and multisystem irAEs during PD-1/PD-L1 inhibitor monotherapy. J Cancer Res Clin Oncol. 149(4):1659-1666(2023). doi: 10.1007/s00432- 022-04425-z.（査読有）

Yamaguchi A, Mukai Y, Sakuma T, Narumi K, Furugen A, Yamada Y, Kobayashi M. Monocarboxylate transporter 4 involves in energy metabolism and drug sensitivity in hypoxia. Sci Rep. 13(1):1501(2023). doi: 10.1038/s41598-023-28558-4.（査読有）

Yasuda G, Kubota A, Okamoto K, Narumi K, Furugen A, Kato I, Mori A, Saito Y, Satoh T, Suzuki-Takahashi N, Iseki K, Kobayashi M. Association between α‐defensin 5 and the expression and function of P‐glycoprotein in differentiated intestinal Caco‐2 cells. Biopharmaceutics & Drug Disposition. 1-7（2023）（査読有）

森綾子，加藤 いづみ，柏木 仁，今井 俊吾，鳴海 克哉，佐藤 夕紀，古堅 彩子，山田 勇磨，小林 正紀， “オンライン会議システムを活用した医療面接実習の実践とその評価” YAKUGAKU ZASSHI. Vol. 142, No.6, 661-674(2022)（査読有）

Yamagami A, Narumi K, Saito Y, Furugen A, Imai S, Kitagawa Y, Ohiro Y, Takagi R, Takekuma Y, Sugawara M, Kobayashi M. Evaluation of the strategies to reduce third-generation oral cephalosporins in dentistry at a Japanese academic hospital: An interrupted time series analysis. J Clin Pharm Ther. 47(7):1010-1019(2022). doi: 10.1111/jcpt.13636. (査読有)

Kobayashi M, Narumi K, Furugen A, Iseki K. Transport function, regulation, and biology of human monocarboxylate transporter 1 (hMCT1) and 4 (hMCT4). Pharmacol Ther. Oct;226:107862. doi: 10.1016/j.pharmthera.2021. 107862. Epub 2021 Apr 22. PMID: 33894276 Review.

Okamoto K, Kitaichi F, Saito Y, Ueda H, Narumi K, Furugen A, Kobayashi M. Antioxidant effect of ascorbic acid against cisplatin-induced nephrotoxicity and P-glycoprotein expression in rats. Eur J Pharmacol. Oct 15;909:174395. doi: 10.1016/j.ejphar.2021. 174395. Epub 2021 Jul 29. PMID: 34332922.（査読有）

Yamaguchi A, Saito Y, Okamoto K, Narumi K, Furugen A, Takekuma Y, Sugawara M, Kobayashi M. Preexisting autoimmune disease is a risk factor for immune-related adverse events: a meta-analysis. Support Care Cancer. Dec;29(12):7747-7753. doi: 10.1007/s00520-021- 06359-7. Epub 2021 Jun 23. PMID: 34164739.（査読有）

Nishimura A, Furugen A, Umazume T, Kitamura S, Soma M, Noshiro K, Takekuma Y, Sugawara M, Iseki K, Kobayashi M. Benzodiazepine Concentrations in the Breast milk and Plasma of Nursing Mothers: Estimation of Relative Infant Dose. Breastfeed Med. May;16(5):424-431(2021) PMID: 33449825.（査読有）

kimura Y, Higuchi I, Kobayashi M, Furugen A, Narumi K, Suzuki Y, Miyoshi H, Nakamura A, Atsumi T, Iseki K. The association between SLC16A11 haplotype and lipid metabolism in Japanese patients with type 2 diabetes.Drug Metabolism and Pharmacokinetics. Volume 37(2021) 100376. PMID: 33561739.（査読有）

Ishikawa S, Kobayashi M, Hashimoto N, Mikami H, Tanimura A, Narumi K, Furugen A, Kusumi I, Iseki K. Association between N-desmethylclozapine and clozapine-induced sialorrhea: Involvement of increased nocturnal salivary secretion via muscarinic receptors by N-desmethylclozapine. J Pharmacol Exp Ther. 2020 Aug 29:JPET-AR-2020-000164. doi: 10.1124/jpet. 120.000164. Online ahead of print. PMID: 32862145.（査読有）

武隈洋，森綾子，小林正紀，山田勇磨，佐藤夕紀，鳴海克哉，古堅彩子，菅原満，“薬学実務実習前後における薬学生のコミュニケーション分析～Roter method of interaction process analysis (RIAS）を用いて～” YAKUGAKU ZASSHI. Vol. 138, No.12, 1579-1586(2018). PMID: 30504673.（査読有）